Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Sglt2 Level'
Sglt2 Level published presentations and documents on DocSlides.
SGLT2 Inhibitors and Their Clinical Impact:
by aaron
Ominous Octet. Renal Handling of Glucose. Active ...
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
Sglt2 inhibitor Dr. NOUSHIN-KHALILI
by roxanne
ENDOCRINOLOGIST. 97.12.7. Diabetes Prevalence in I...
JARDIANCE:
by sherrill-nordquist
Newly Approved Drug to Lower HbA1C in Type-2 diab...
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
by debby-jeon
DKA, a subset of ketoacidosis or ketosis in diabet...
Updates on CVOT Data and Clinical Comparisons That Matter
by pamella-moone
This program will include a discussion of off-lab...
Oral Hypoglycemics
by danika-pritchard
Roland Halil, . BScPharm, ACPR, PharmD. Clinical ...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Updates Abound Introduction
by sherrill-nordquist
GLP-1 RAs in Combination With Basal Insulin Appro...
Development Committee CHAIR
by kittie-lecroy
Lawrence A. Leiter, Endocrinology & Metaboli...
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
by yoshiko-marsland
Type 1 Diabetes: Expanding Options for Adjunctive...
Diabetes and Hypertension Accelerate Glomerular Hypertension
by aaron
Circulation 2014;129:587-597. Teaching Tool: Hype...
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科
by jideborn
Department of Endocrinology and Diabetes, . Saitam...
Oral hypoglycemics Jennifer R Marks, MD
by finley
Oral hypoglycemics. Factors to consider:. Cost. Av...
Shifting Paradigms in the Selection of
by alyssa
Antidiabetes. Medications:. Cardiovascular Benefi...
Diabetes treatment options
by StarDust
Dr Theingi Aung. Endocrinologist. Royal Berkshire ...
Highlights from ACC 2021
by maisie
Virtua – May 15-17, 2021. ACC 2021 Highlights . ...
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
by ishaan
John McMurray. BHF Cardiovascular Research Centre,...
Load More...